Secretory component‐dependent binding of immunoglobuin A in the rat, monkey and human: A comparison of intestine and liver

Christopher K. Daniels, Douglas L. Schmucker – 1 May 1987 – The source and significance of immunoglobulin A in bile remains controversial. In the rat, and several other species, immunoglobulin A is transported through hep‐atocytes by a specific receptor, secretory component. In humans, immunohistochemical methods have indicated a distinct lack of receptors for immunoglobulin A on hepatocytes. Binding assays with 125I‐immunoglobulin A and membranes from hepatocytes and intestinal cells of the rat display secretory component‐dependent binding.

Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes

Dennis R. Feller, Yogendra Singh, Vilas R. Shirhatti, Thomas A. Kocarek, Cuo‐Tung Liu, Gopal Krishna – 1 May 1987 – We have determined the comparative activities of peroxisomal proliferators, ciprofibrate and clofibric acid on various hepatic parameters associated with endoplasmic reticulum, mitochondria and peroxisomes in primary cultures of rat hepatocytes.

The jaundiced heart

Lawrence Deckelbaum – 1 May 1987 – Patients with obstructive jaundice are susceptible to postoperative shock and kidney failure. The cause of these potentially fatal complications has not been fully clarified. The present study was designed to assess the role of myocardial dysfunction in the hemodynamic disturbance of obstructive jaundice. We studied the effect of isolated cholemia on left ventricular performance in five conscious dogs before and 2 weeks after choledochocaval anastomosis by using measurements of systolic time intervals (STIs) and maximal dp/dt.

Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis

Maria H. Sjogren, Jay H. Hoofnagle, Jeanne G. Waggoner – 1 May 1987 – Serum levels of antibody to hepatitis B core antigen and IgM antibody to hepatitis B core antigen were tested in 15 patients who participated in a randomized, placebo‐controlled trial of a 28‐day course of prednisolone therapy. During treatment, serum levels of antibody to hepatitis B core antigen and IgM antibody to hepatitis B core antigen decreased in all 10 treated patients, but in none of five controls (p < 0.05).

Modulation of the immunological response to hepatitis b virus by antibodies

Esteban Celis, Katalin G. Abraham, Richard W. Miller – 1 May 1987 – Antibodies to HBsAg of IgG class enhanced the helper activity of a human T cell clone to promote the in vitro synthesis of immunoglobulins by autologous B lymphocytes. Using two different assay systems, the effect of antigen‐specific antibodies on the helper function of a HBsAg‐reactive T cell clone was studied. The monoclonal antibody to HBsAg A5C3 (IgG) increased significantly the T cell‐dependent production of immunoglobulins by Staphyloccocus aureus‐stimulated autologous B lymphocytes.

Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens

Gretchen M. Hill, George J. Brewer, Ananda S. Prasad, Connie R. Hydrick, Deborah E. Hartmann – 1 May 1987 – The standard therapy for preventing copper accumulation in Wilson's disease, D‐penicillamine, has been a life‐saving drug, but it has many side effects and some patients are completely intolerant. We have been using oral zinc as another approach to the therapy for Wilson's disease, with copper balance studies as the key initial assessment of the adequacy of a given dose or regimen of zinc therapy.

Interrelationship between splenic and superior mesenteric venous circulation manifested by transient splenic arterial occlusion using a balloon catheter

Osamu Nishida, Fuminori Moriyasu, Takefumi Nakamura, Nobuyuki Ban, Kensuke Miura, Masahiko Sakai, Haruto Uchino, Takeo Miyake – 1 May 1987 – We examined the hemodynamic changes induced by transient splenic arterial occlusion using a balloon catheter to investigate the hemodynamic effect of transcatheter splenic arterial embolization—a procedure that has been used since its introduction in 1973 as therapy for hypersplenism and more recently for portal hypertension.

Subscribe to